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High-dimensionality data is rapidly becoming the norm for biomedical sciences and many
other analytical disciplines. Not only is the collection and processing time for such data
becoming problematic, but it has become increasingly difficult to form a comprehensive
appreciation of high-dimensionality data. Though data analysis methods for coping with
multivariate data are well-documented in technical fields such as computer science, little
effort is currently being expended to condense data vectors that exist beyond the realm
of physical space into an easily interpretable and aesthetic form. To address this important
need, we have developed Plurigon, a data visualization and classification tool for the
integration of high-dimensionality visualization algorithms with a user-friendly, interactive
graphical interface. Unlike existing data visualization methods, which are focused on
an ensemble of data points, Plurigon places a strong emphasis upon the visualization
of a single data point and its determining characteristics. Multivariate data vectors are
represented in the form of a deformed sphere with a distinct topology of hills, valleys,
plateaus, peaks, and crevices. The gestalt structure of the resultant Plurigon object
generates an easily-appreciable model. User interaction with the Plurigon is extensive;
zoom, rotation, axial and vector display, feature extraction, and anaglyph stereoscopy
are currently supported. With Plurigon and its ability to analyze high-complexity data,
we hope to see a unification of biomedical and computational sciences as well as
practical applications in a wide array of scientific disciplines. Increased accessibility to
the analysis of high-dimensionality data may increase the number of new discoveries
and breakthroughs, ranging from drug screening to disease diagnosis to medical literature
mining.
Keywords: Plurigon, three dimensional, data visualization, data classification, multivariate data vectors,
algorithms, systems biology, bioinformatics
INTRODUCTION
With the advent of large-scale repositories of scientific knowledge
and the increasing prevalence of information science, researchers
from multiple disciplines are often faced with the task of collect-
ing, manipulating, and disseminating high-dimensionality data.
Currently, the model of choice for dealing with such data is the
vector space model, a system of representing any entity with a
list of identifiers in vector form. For example, high-throughput
screening assay data from PubChem presents each compound
in their database as a 881-dimensional binary vector represent-
ing the absence or presence of various features (elements, ring
systems, atom pairing, nearest neighbors) in the compound.
Similarly, a list of experimental results from any test subject can be
equated to a vector with a dimensionality equal to the cardinality
of the number of tests performed.
Such amodel is undoubtedly invaluable for its condensation of
data into a computable space. However, with increasing dimen-
sionality, various numerical analysis challenges such as sparse-
ness, statistical insignificance, and computational difficulty arise
(Bellman, 1957). For classification, Vapnik-Chervonenkis theory
and the Hughes effect state that theoretical classification rate
decreases as dimensionality increases (Hughes, 1968). To address
these issues, data is often preprocessed with feature extraction and
dimensionality reduction techniques. Reducing dimensionality
allows data to be processed more quickly and leads to reductions
in noise, sparseness, and redundancy.
Additionally, as vectors often extend the scope of physical
space, data visualization becomes an issue. Unfortunately, since
presenting information in graphical ways is not necessary for
our ability to extract answers, the field of data visualization lags
far behind its sister disciplines of data analysis and data mining
(Fayyad et al., 2002). This occurrence has led to a system in which
only highly-specialized experts in esoteric technicalities can inter-
pret the data at hand. If high-dimensionality data hopes to gain
a larger audience however, advanced data visualization is instru-
mental in allowing end users with a rudimentary understanding
of complex mathematics to interpret the graphical metaphors of
the data at hand.
There are currently several excellent examples of high-
dimensionality data visualization software including Ggobi
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(http://www.ggobi.org/), Visumap (http://www.visumap.net/)
and Iris from Ayasdi (http://www.visumap.net/). It is clear
from the applications of these programs (Wurtele et al., 2003;
Landauer et al., 2004; Nicolau et al., 2011; Lum et al., 2013)
that the inclusion of the exquisite capacity for human-centric
visual appreciation and recognition into complex data analysis
is a fertile ground for future research into high-dimensionality
data interpretation. Plurigon serves to further this current inter-
est and provide a synergistic alternative to these already useful
applications.
Plurigon provides unification of high-dimensionality algo-
rithms with visual human interfaces by converting a vector that
exceeds physical space into an easily interpretable and highly
interactive three-dimensional object. Feature extraction can then
be performed on the Plurigon, either visually or computation-
ally, for classification or machine learning. The usage of these
features for data analysis is unexplored but promising due to
the ease of Plurigon visual interpretation. The most unique trait
of the Plurigon is that it is currently the only data visualiza-
tion technique that places an emphasis on individual data vec-
tors as opposed to an ensemble of different data vectors. This
aspect of Plurigon provides an alternative to other forms of
high-dimensional data visualizers. For example, genes or pro-
teins are likely to act in two different modes, at times there
may be strong individual actions (e.g., amyloid precursor pro-
tein mutations in Alzheimer’s disease; Maudsley and Mattson,
2006) while at other times a specific gene/protein may act in
a collective manner with other genes/proteins (Mootha et al.,
2003). In most physiological systems a combination of these two
functional modes is likely to be apparent, and especially in the
presence of relatively few data points, Plurigon may provide a
valuable alternative to ensemble visualization. In addition, the
actual physiological actions of gene transcripts or proteins are
highly contextual, i.e., a gene or a protein may possess a wide
range of potential functionalities, but depending on the activ-
ity of other functionally-related or physically proximal factors,
this spectrum of activity may be both qualitatively and quan-
titatively affected. By creating a data-derived physical object we
intend to allow the influence of each individual piece of data with
each other to create a form that encodes all potential interactions
via the revelation of a recognizable series of topologies. These
structures therefore may be characteristic of the actual “gestalt”
output of the altered series of genes/proteins in the physiological
paradigm.
With the Plurigon, data mining and knowledge discovery
are more easily accessible to everyone—providing for integrated
solutions between the biological and computational sciences.
Increased accessibility to the analysis of high-dimensionality data
may increase the number of new discoveries and breakthroughs
in science, ranging from drug screening to literature mining.
MATERIALS AND METHODS
DETERMINATION OF VERTICES ON THE PLURIGON
For an input of n-values corresponding to a vector in n-
dimensional space, a Plurigon can be generated without loss as
a set of spherical coordinates (r, θ, ϕ). While the radius cap-
tures the magnitude of each value θ, ϕ captures its location
in the original vector. Transformation of a data set into a
Plurigon structure requires three steps: generation of a proto-
type structure with equal radii, remapping every point in the
prototype to reflect actual data values, and iterative smoothing
of the resulting Plurigon to remove sharp edges and unaesthetic
qualities.
The vertices of the prototype Plurigon are generated by spac-
ing n points on the prototype’s circumsphere as far as possible.
Unfortunately, this is a non-trivial task. Due to Euclid’s proof
that there are only five platonic solids, perfectly spaced points
on a cube can only be achieved for dimensions 4, 6, 8, 12, and
20. In all other dimensions, perfect spacing cannot be achieved;
however, there are a number of methods for approximating a
distribution that minimizes the variance in distance between
points. It is important to note that the naïve method of choos-
ing points at equally spaced intervals of θ and ϕ is insufficient
because data points aremuchmore concentrated near the sphere’s
poles (Cook, 1957). As such, current methods for spacing vertices
on a sphere include hypercube rejection, creation of a simu-
lation involving electron repulsion, and spiral tracing (Smith,
1984; Rakhmanov et al., 1995; Saff and Kujilaars, 1997; Thomsen,
2007).
For its ability to run in linear time, we use a slight improve-
ment, created by Thomsen (2007), upon the methodology devel-
oped by Saff et al. for spacing points (Saff and Kujilaars, 1997), in
which a larger spacing between the highest and lowest point bet-
ter promotes point sparseness. This method falls into the category
of spiral tracing, where a spiral is constructed with the endpoints
as the sphere’s poles and vertices placed at equal distances along
the line segment (Figure 1A).
GENERATION OF A POLYGONALMESH FROM THE VERTICES
Optimal generation of faces from the prototype’s vertices requires
performing the Delaunay triangulation on the set of points
(Delaunay, 1934; Lee and Schachter, 1980). Briefly, the Delaunay
triangulation of a set of points, P, in two dimensions is defined
as the triangulation, T, in which no point in P rests in any cir-
cumcircle of any triangle in T. Although Delaunay triangulation
is always possible in two dimensions, when considering exten-
sions to higher dimensions, triangulations are often impossible
or not unique. Fortunately, in the case of points of equal radius
from a sphere’s center of mass (COM), Delaunay triangulations
are not only always possible, but also computable via taking the
convex hull of the collection of points. Since there are no points
within the sphere, a convex hull should encompass all vertices on
the Plurigon prototype.
Generation of a convex hull in n-dimensions is well docu-
mented in the field of computer science. Since the inception of the
Jarvis march (O(n2))method for computing convex hulls in 1973,
a variety of algorithms have been discovered and employed with
much lower time-complexity (Graham, 1972; Jarvis, 1973). Here
we use the QuickHull (O(n log n)) divide-and-conquer algorithm
outlined in Barber et al. for the construction of the prototype’s
triangular faces (Barber et al., 1996). The resulting three dimen-
sional polyhedron contains n vertices, n triangular faces, and can
be contained in a circumsphere such that all vertices rest on its
surface (Figure 1B).
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FIGURE 1 | Generation of Plurigon structure and its general
manipulation. (A) Initial Plurigon backbone creation. An illustration of
vertex placement through spiral tracing. A set of 50 points was placed on
the sphere at approximately equal distances from each other. (B) Plurigon
polygonal basic structure. Convex hull generated from the vertices shown
in (A). This is the completed version of the Plurigon prototype; radial
distance to the core remains constant for all vertices. (C) Laplacian
smoothing in progress. Data was taken from a subset of gene expression
values from murine genomic expression data. Iterations shown are i, ii, iii,
iv, and v, afterwards, the movement of points becomes negligible, so
iteration is stopped. (D) Initial Plurigon interface. The basic start-up
Plurigon is depicted in an image window. (E) Simple and advanced
Plurigon operations. Pressing “o” initiates the ability to choose a specific
file to be depicted (1). Loading and pre-processing of data text file results
in the generation of the basic color-coded Plurigon (2). Rotation of the
Plurigon in all three dimensions is achieved using the up/down and
left/right cursor keys. Addition of any other visualization features onto the
Plurigon does not affect the rotational capacity. Pressing “x” generates the
superimposition of x, y, and z axes onto the Plurigon (3). Pressing “x”
while the three axes are present toggles the axes off. This action format is
conserved for all other forms of Plurigon visualization. Pressing “c”
superimposes the vector position for the Plurigon center of mass (COM)
(4). This COM is represented by a red line. Pressing “+” or “−” generates
an ability to zoom in and out of the Plurigon (5). A 3-dimensional (3-D)
viewing version of the Plurigon is generated by pressing the number “3”
(6). Pressing “3” again while in the 3-D mode removes this visualization
format. Simple output of basic Plurigon structural information is achieved
by pressing “i” (7). The ability to save a TIFF picture file of the window
view of the Plurigon is achieved by pressing “s.” For each of the functions,
sequential superimposition upon the Plurigon can be achieved using the
respective key functions. For export to further 3-D viewing applications
a.vrml/.wrl file of the Plurigon can be generated by pressing “v” (8). The
image depicted is viewed using a Cortona-3D viewing application
(www.cortona3d.com/Products/Viewer/Cortona-3D-Viewer.aspx).
CREATION OF THE PLURIGON FROM A PROTOTYPE
The purpose of creating a prototype is to ensure that the number
of vertices on the resulting Plurigon is the same as n, the
dimensionality of the data vector, during calculation of the con-
vex hull. This was calculated with a unit vector to ensure that
no points are located in the interior of the sphere. After calcu-
lation of the convex hull, the radii, r, of the prototype must be
replaced by the individual input data values. The resulting sur-
face should still be continuous, though during this phase it will
likely be excessively turbulent and undulating for aesthetic and
interpretable viewing.
To address this issue, the surface of the Plurigon must be
smoothed and normalized until distinct topographic features,
i.e., troughs, hills, peaks, and crevices, can be viewed. To this
end, iterative Laplacian smoothing is applied to the polygonal
mesh. Laplacian smoothing is a widely used technique in a vari-
ety of scientific fields (Briere and George, 1995; Amenta et al.,
1997; Canann et al., 1997). Since its inception, many optimiza-
tions and improvements have improved the aesthetic outcomes
of the smoothing process. Most notably, it has become possible
to smooth a surface while maintaining Delaunay triangulation
(Herrmann, 1976; Field, 1988; George and Borouchaki, 1998).
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Sincemaintenance of the Plurigon’sDelaunay triangulation is cru-
cial, a version of the smoothing algorithm outlined in (Field,
1988) was used. After a certain amount of iterations, where
the movement of vertices becomes negligible, iteration is termi-
nated and a highly smooth surface with distinct contours can be
observed (Figure 1C).
EXTRACTION OF RUDIMENTARY FEATURES
As an example of Plurigon’s feature extraction capabilities, the
latest release of Plurigon facilitates the automated calculation of
a small number of built-in global features. The COM is calcu-
lated by converting spherical coordinates to cartesian coordinates
and then computing the mean of the x-,y-, and z-values. Average
radius to the Plurigon’s core, i.e., the origin, is calculated by
the mean of all radial values. Finally, surface area is computed
by applying Heron’s formula to each of the Plurigon’s n faces.
Other advanced features that can be extracted from Plurigons that
may facilitate integration with other interaction-based technolo-
gies such as tangible user interfaces (TUIs) (Ratti et al., 2004),
but are not included in the program for their length of com-
pute time include: angular momentum for spinning Plurigons,
linear momentum for moving Plurigons, and recognition of
specific local analogous features (valleys, hills, peaks, crevices)
with automated pattern recognition. With ease of human visu-
alization and interpretation, however, specific feature extraction
algorithms can be generated to suit the specific experiment at
hand. It is interesting to note, however, that feature extraction
may be infeasible for certain applications. Despite the superfi-
cial simplicity of Plurigon structures for the visual appreciation of
complex datasets, simple machine-based feature extractions can
rapidly become computationally impractical. For example, the
triangulation of the Plurigon into tetrahedrons cannot be com-
puted in polynomial time and is NP-hard (Freund and Orlin,
1985).
FUNCTIONAL FEATURES OF PLURIGON
The Plurigon interface exists as a Java application in either
Windows, Mac OSX, or Linux formats. Plurigon is freely available
for download from the National Institute on Aging/National
Institutes of Health website (http://www.irp.nia.nih.gov/
bioinformatics/plurigon.html) (Figure S1). For review purposes,
we have uploaded a Windows and Mac version of Plurigon for
the reviewers and editor to test. The Plurigon application can
be controlled entirely by keyboard (Figures 1D,E). Pressing
“o” initiates the ability to choose a specific file to be depicted
(Figure 1D). Loading and pre-processing of data text file results
in the generation of the basic Plurigon (Figure 1E). Rotation
of the Plurigon in all three dimensions is achieved using the
up/down and left/right cursor keys. Addition of any other
visualization features onto the Plurigon does not affect the
rotational capacity. Pressing “x” generates the superimposition
of color-coded (pink, yellow and blue) x, y, and z axes onto the
Plurigon. Pressing “x” while the three axes are present toggles
the axes off. This action format is conserved for all other forms
of Plurigon visualization. Pressing “c” superimposes the vector
position for the Plurigon COM. This COM is represented by a red
line. Pressing “+” or “−”generates the ability to zoom in and out
of the Plurigon. A 3-dimensional (3-D) viewing version of the
Plurigon can be generated by pressing the number “3.” Pressing
“3” again while in the 3-D mode removes this visualization
format. Output of basic Plurigon structural information is
achieved by pressing “i.” The output information box details
the three dimensional coordinates of the calculated COM (x, y,
z—format), the average radius of the plurigon structure from
the central core of the platform (Avg.Rad.Core) and the total
plurigon surface area (Surface Area). For future versions of
Plurigon additional feature extraction tools will be developed
(see Conclusions). The ability to save a TIFF picture file of the
window view of the Plurigon is achieved by pressing “s.” For
each of the functions, sequential superimposition upon the
Plurigon can be achieved using the respective key functions. For
export to further 3-D viewing applications a.vrml/.wrl file of the
Plurigon can be generated by pressing “v.” The image depicted
can be viewed using a Cortona-3D viewing application (www.
cortona3d.com/Products/Viewer/Cortona-3D-Viewer.aspx).
MURINE HYPOTHALAMIC TRANSCRIPTOMIC INVESTIGATION
Wildtype C57BL6 mice were housed and employed in accordance
with the Animal Care and Use Committee (ACUC) regulations
at the NIH National Institute on Aging. Briefly, mice, three per
age (3, 6, 12, and 18 months of age) and gender group (male,
female), were humanely sacrificed and their hypothalamic tis-
sue was excised rapidly and snap frozen for Illumina Fluorescent
Gene Array analysis as described previously (Martin et al., 2012b).
HETEROZYGOUSGENOTYPE TRANSCRIPTOMIC INVESTIGATION
Four month old male wildtype C57BL6 (WT) and G
protein-coupled receptor kinase-interacting transcript 2
(GIT2)-heterozygous (GIT2−/+ , aka HET) mice were housed
and employed in accordance with the ACUC regulations at the
National Institute on Aging. Briefly, multiple mice from both
genotype groups (WT or HET) were humanely sacrificed and
tissue extracts from the following organs were prepared for gene
array analysis: hypothalamus, hippocampus, skeletal muscle,
liver, pituitary gland and testes. For Plurigon analysis a similar
tissue-based range of transcriptomic data was simultaneously
analyzed for both genotypes under study, i.e., WT and HET.
ANTI-NEURODEGENERATIVE TRANSCRIPTOMIC INVESTIGATION
Clonal human neuronal cells, SH-SY5Y, were employed to study
the pro-neurotrophic actions of the tri-cyclic antidepressant
amitriptyline (AMI). SH-SY5Y cells (American Type Culture
Collection) were maintained in a humidified 5%CO2 atmosphere
at 37◦C as described previously (Chadwick et al., 2010). We
have previously demonstrated that in an aging-neurodegenerative
murine model AMI exerts strongly neurotrophic pharmaco-
logical activity. We therefore employed Plurigon to investigate
and analogize the activity of AMI compared to endogenous
classical neurotrophic peptides such as brain-derived neu-
rotrophic factor (BDNF) and nerve growth factor (NGF).
Transcriptomic responses to AMI (10 nM), BDNF (10 ng/mL) or
NGF (10 ng/mL) stimulation (8 h) of SH-SY5Y cells were assessed
as previously described (Martin et al., 2009; Chadwick et al.,
2012). AMI-hydrochloride, BDNF and NGF were all obtained
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from Sigma Aldrich (St. Louis, MO). In addition to assessing the
transcriptomic responses of these human neuronal cells to AMI,
BDNF, and NGF we also assessed the same activity responses
in SH-SY5Y cells pre-treated with a chronic minimal peroxide
exposure protocol designed to mimic age-related neurodegenera-
tion (Chadwick et al., 2010; Martin et al., 2012a). This oxidative
insult consists of a chronic (7 days) exposure to a survivable and
minimal concentration (10 nM) of the oxidizing agent hydro-
gen peroxide. Transcriptomic responses to these three ligands,
AMI, BDNF, and NGF, were measured as described previously.
In addition to transcriptomic effects, protein expression profiles
for various proteins were assessed using selective antibody-based
western blotting and immunoprecipitation procedures described
previously (Maudsley et al., 2000). Western blotting procedures
were as performed previously (Martin et al., 2009): the sources
of the primary antibodies employed in this study are detailed
in Table S1. Subcellular fractionation of SH-SY5Y cell proteins
was performed to separate intracellular proteins between Golgi
and endoplasmic reticular compartments as described in Ko and
Puglielli (2009).
RESULTS AND DISCUSSION
DESCRIPTION OF PLURIGON GENERATION AND THE USER INTERFACE
The Plurigon software application aims to facilitate the transfor-
mation of high-volume data into a simpler, more appreciable
structure. We term this resultant three-dimensional structure
a “plurigon.” To create this data structure we use spiral trac-
ing, where a spiral is first generated with the endpoints as the
sphere’s poles and vertices placed at equal distances along the
line segment (Figure 1A). We then use a divide-and-conquer
algorithm to generate a solid figure with triangular faces on the
three-dimensional solid contained in a circumsphere with all the
vertices resting on its surface (Figure 1B). After data input and
data-magnitude color-coding, surface smoothening and normal-
ization is applied to generate a more aesthetic Plurigon with more
easily-appreciable contoured topography (Figure 1C). A detailed
description of the Plurigon-generating computational steps is out-
lined in the Materials and Methods section and a flowchart of
the functional data transition through Plurigon is depicted in
Figure S2. Plurigon is available as a lightweight, standalone Java
application, and as with other visualizers such as Ggobi, is avail-
able in versions for Windows, Mac OSX, and Linux. Untagged
data can be uploaded into the Plurigon program with a.txt file
containing precisely three floating-point numbers per line delim-
ited by newlines. For direct comparison of comparable data, e.g.,
similar denominating factors with variable numerators, appro-
priate pre-processing should be performed by the user. Memory
and computational requirements for Plurigon are markedly low.
The algorithm for Plurigon generation outlined in the Materials
and Methods section is highly scalable because of its logarith-
mic time-complexity. As a result, graphics rendering is typically
smooth even on very large data sets (∼20—40,000 features) and
with low-end computers (<256MB Random Access Memory).
Rendering is typically instantaneous with frame rates of over
30 in practice. Plurigon is accessible completely from the key-
board. User functionality for visualization, portability, and inter-
action is extensive, as described in section Functional Features
of Plurigon. Plurigons are automatically normalized to empha-
size differences within data sets. Additionally, peaks, plateaus, and
troughs within the Plurigon are color-coded with varying shades
of red (highest value scores), gray, and cyan (lowest value scores),
respectively.
VISUALIZATION OF HIGH DIMENSIONALITY DATA SETS
Visualization of high-dimensionality data sets provides for the
clear communication of information, unites various scientific dis-
ciplines, and makes otherwise arcane or highly-cryptic informa-
tion more easily accessible. The current state of data visualization
revolves around the representation of data matrices—an ensem-
ble of data points. For example, when data is sparse and slight
information loss is not an issue, a common practice is to per-
form Principal Components Analysis (PCA) to extract three or
fewer components and then graph the resulting data points in
a three-dimensional scatterplot (Wold et al., 1987; Kim et al.,
2007). Other methods have been developed for even larger data
sets. Two online visualization suites, Mondrian (http://mondrian.
pentaho.com/) and Ggobi, both employ polylines with parallel
coordinates, a common method for visualizing multivariate data
by drawing n equally-spaced, parallel, vertical lines and plotting
data along each line (Swayne et al., 1998; Theus, 2002; Buja et al.,
2003; Cook and Swayne, 2007). Despite the considerable attention
given to the relationships between data vectors, each individual
vector is often neglected. For example, Ggobi represents a single
data vector as a linear chain, which can quickly become chaotic
and unintelligible once dimensionality exceeds a certain thresh-
old. Plurigon provides for an alternative visualization mechanism
by placing the emphasis not on the ensemble of data points, but
rather on the individual data points themselves. The chaos of a
single Ggobi linear chain is not present in the compact, spheri-
cal representation of the Plurigon even with dimensionalities in
the tens of thousands. The effective employment of multiple dis-
tinct strategies for data investigation is likely to provide adequate
solutions for a wide range of scientists. For Plurigon emphasis is
dedicated to the prominence of a single, high-dimensionality data
vector, whether it be a test subject, a compound, a document, or a
gene. Strong deformities in topography could potentially be iden-
tified as important features. Despite the emphasis on individual
points, however, there still exists a capacity for visualizing mul-
tiple subsets of vectors in a data matrix by comparing multiple
Plurigons simultaneously for structural analogies or by subtract-
ing or averaging data vectors with a data preprocessor before
visualization.
PRACTICAL EMPLOYMENT OF PLURIGON
As Plurigon represents a versatile tool that can be applied to multi-
ple forms of biomedical investigation we chose to use it to interro-
gate three data from three distinct but functionally-related sets of
transcriptomic data. The three experimental paradigms we used
to investigate the implementation of Plurigon are all associated
with the study of aging and age-related neurodegeneration. The
first paradigm (Plurigon Investigation of Murine Hypothalamic
Aging Profiles) involves scrutiny of gender-based aging in the
hypothalamus (a core central nervous system tissue for the con-
trol of aging). The second paradigm (Plurigon Investigation of
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Complex Murine Genotypic Profiles) challenges the ability of
Plurigon to identify and classify large transcriptomic datasets
from animal tissues from wildtype and heterozygous transgenic
mice with reduced expression of a protein crucial for aging,
GIT2 (G protein-coupled receptor kinase-interactor 2: Chadwick
et al., 2012). The final paradigm (Plurigon Investigation of Novel
Drug-Response Profiles) uses Plurigon to investigate novel anti-
neurodegenerative drug mechanisms.
Plurigon investigation of murine hypothalamic aging profiles
We have previously identified the hypothalamus as one of the
most important physiological loci for both aging and neurode-
generative activities (Chadwick et al., 2012; Martin et al., 2012b).
In the current study, we employed hypothalamic gene tran-
scriptomic data from wildtype mice, of both genders, across
a broad age range (6, 12, 18 months) (Figure 2; Tables S2–S4
Female, Tables S5–S7 Male). After uploading of the transcripts
consistently regulated across all three mouse ages (compared
to 3 month old controls) for both genders there is a clear
hypothalamic Plurigon structural “evolution” with the increasing
age (Figure 2A: Female; Figure 2D: Male). As a simple indicator
of the utility of our Plurigon program, we have just taken one out-
put function, i.e., the COM calculation, to demonstrate an ana-
lytical function of our program. Using the Cartesian r, transform
for the three spherical coordinates (x,y,z) we found that there
are statistically significant changes (p < 0.05 see Figures 2; B,C
Female, E,F Male) in the COM output with age in both females
and males. Therefore, with relatively simple feature extraction
Plurigon is able to generate easily-appreciable models of simple
transcriptomic data associated with highly complex biological
functions such as aging. The addition of further feature extrac-
tionmodes will undoubtedly aid further structural differentiation
pipelines.
Plurigon investigation of complex murine genotypic profiles
In addition to employing Plurigon for relatively small datasets
we also introduced a considerably larger data burden to Plurigon
to assess its ability to separate highly complex transcriptomic
FIGURE 2 | Aging-related structural alteration in hypothalamic
Plurigons. (A) Panels 1, 2, and 3 represent plurigons created from
hypothalamic transcriptome data from female mice of 6 (F6), 12 (F12), and
18 (F18) months of age, respectively. Panels 4, 5, and 6 indicate the
identical coordinate nature of the three plurigons in 1–3. (B) Coordinate
values, x, y, and z for the center or mass (COM) for the F6, F12, and F18
plurigons. (C) Calculation of r, (((x2) + (y2) + (z2))1/2), for F6, F12, and
F18 plurigons. Statistical significance (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001)
was measured with GraphPad Prism (Student’s t-test) for F12 and F18
relative to F6. (D) Panels 1, 2, and 3 represent plurigons created from
hypothalamic transcriptome data from male mice of 6 (M6), 12 (M12), and
18 (M18) months of age, respectively. Panels 4, 5, and 6 indicate the
identical coordinate nature of the three plurigons in 1–3. (E) Coordinate
values, x, y, and z for the center or mass (COM) for the M6, M12, and
M18 plurigons. (F) Calculation of r, (((x2) + (y2) + (z2))1/2), for M6, M12,
and M18 plurigons. Statistical significance (∗∗p < 0.01, ∗∗∗p < 0.001) was
measured with GraphPad Prism (Student’s t-test) for M12 and M18
relative to M6.
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data. To this end we also endeavored to assess whether Plurigon
could effect a data group separation that was not achievable
using PCA to three dimensions. We have therefore compared
two heterogeneous, but functionally-related, groups of data, i.e.,
transcriptomic data from multiple murine tissues from either
wildtype (WT) mice or mice with a heterozygous condition for
the aging-regulator, GIT2 (Chadwick et al., 2012). GIT2 has
been demonstrated to exert multiple cellular effects in mice
(Schmalzigaug et al., 2009; Chadwick et al., 2010, 2012; Wang
et al., 2012) therefore reduction in the expression of this impor-
tant gene is likely to cause systemic effects in the animal, there-
fore there should be multiple differences in the transcriptomes
between WT (n = 17) and the HET (n = 19) mice. Therefore,
we employed Plurigon to attempt to separate these two sets of
data (Table S8 WT, Table S9 HET). For these two genotypic
examples our data corpus for each set has a dimensionality of
over 20,000. Generating and scrutinizing individual plurigons for
each mouse dataset (36 in total), therefore we initially chose to
investigate whether systemic differences could be visually distin-
guished between “mean” plurigons for each genotype (Figure 3).
We found that visual user scrutiny of both exemplary individual
and the mean plurigons for each genotype facilitated the iden-
tification of complex and genotype-specific structural features
(Figures 3A–C, S3–S7). We were also able to re-trace the ori-
gins of structural features observed in the mean plurigons back
to individual animal plurigon data (Figure 4). Using visual user-
based scrutiny it is clear that additional levels of data description
can be generated with three dimensional plurigons, i.e., structural
encryption and topological analogy. The presence or absence of
view-obscuring factors can present or reveal distinctive features
to the viewer that are discriminatory between complex datasets
(Figure 3). Visual scrutiny is particularly good at quickly dissemi-
nating critical differences from less significant differences, even in
large data sets. Plurigon outperforms PCA in this regard by virtue
of being lossless. Distinctive features on the Plurigon can theoret-
ically be mapped back to the individual dimensions by a second
pass through the generation process. In this respect a counterpart
for PCA does not exist.
We also found that structural topologies were also useful as
characteristic agents, especially when compared to PCA-based
analyses. Upon applying standard PCA algorithms, down to three
dimensions, to the 36 mouse datasets we found the two dis-
tinct groups, WT or HET were non-linearly separable (Table S10:
Figure S8). Unfortunately one of the main drawbacks of PCA
is its inability to handle non-linearity, however human visual
objects categorization however can help in this issue. Hence while
PCA was unable to distinguish between the two groups we found
that running a linear SVM (support vector machine) classifier
on the genotypic data perfectly separates the two groups in 36
dimensions, suggesting that there are discriminatory structural
plurigon features even in this reduced state. As the plurigons
themselves are highly complex structures we computationally dis-
covered structural motifs that support this genotype discrimina-
tion. Firstly we reduced the complexity of theWT/HET plurigons
(with PCA) down to 36 dimensions for simpler visualization.
Secondly we algorithmically selected three structural regions that
could result in near-perfect separation of the genotypic data.
FIGURE 3 | Plurigon-mediated investigation into genotypic data
patterns. (A) Exemplary plurigons generated from either a wildtype
C576Bl6 mouse (WT) or a GIT2−/+ heterozygous mouse (HET). (B) Mean
WT (panel 1) and HET plurigons (panel 2). Panels 3 and 4 indicate the
identical coordinate nature of the two mean plurigons in panels 1 and 2.
The yellow inset box indicates a region of structural idiosyncrasy between
the mean WT and HET plurigons. This yellow inset box is expanded in
panels 5 and 6 with associated arrows highlighting the structural variation.
(C) Representation of a secondary structural variation in mean WT or HET
plurigons. The panel numbering and content is identical to (B).
Analyzing the three dimensional nature, convex (denoted by v)
or concave (denoted by c), of the three specific regions we found
that their relationship to each other engendered the near-perfect
data separation (Figure 5). The order of structure of these three
faces (highlighted in red, green or blue) was therefore able to
strongly discriminate the WT group (v-v-c or v-c-v) from the
HET group (c-v-c or v-v-v) (Figure 5: Table S11). Therefore, in
this circumstance it seems that using the structural nature and
topographical data extraction of Plurigon can offer some assis-
tance where classical three dimensional PCA is limited. Linked
to this, one important feature of Plurigon is that it can retain
an arbitrary number of dimensions (in this case 36) while visu-
alizable PCA is limited to two or three dimensions. Both PCA-
and Plurigon-mediated analysis possess benefits and flaws and the
implementation of them will depend on the eventual user prefer-
ence, nature of the dataset and also the specific questions asked of
the data.
Plurigon investigation of novel drug-response profiles
Over the past decade our appreciation of the potential com-
plexity of drug responses has necessitated the development of
higher-density drug-response data (Maudsley et al., 2005, 2011b;
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FIGURE 4 | Individual plurigon basis for structural variation in mean
plurigon structures. (A) Mean WT (B-coordinate location version) and mean
HET (C,D-coordinate location version) are depicted with a region of structural
diversity between them highlighted in the yellow inset box (B-WT, D-HET).
Panels (E) and (F) indicate these expanded regions from the yellow inset
boxes in (B) and (D). The three projecting features creating the structural
diversity are denoted as α, β, and γ. For the feature highlighted in (E), three
individual WT plurigon regions (E-i–E-iii ) containing and potentially
underlying the three projecting features (α, β, γ) are indicated. For the same
generic feature indicated in the HET mean plurigon in panel (F), three
additional HET plurigon regions (F-i–F-iii ) containing and potentially
underlying the three projecting features (α, β, γ) are indicated.
FIGURE 5 | Topographical data analysis with Plurigon. (A–C) Exemplary
topologically color-coded, and dimensionally-reduced, plurigons from the
WT data corpus. The three demonstrated plurigons demonstrate a
structural tripartite motif of convex [(v) red]—concave [(c) green]—convex
[(v) blue]. (D–F) Exemplary topologically color-coded, and
dimensionally-reduced, plurigons from the HET data corpus. The three
demonstrated plurigons demonstrate a structural tripartite motif of concave
[(c) red]—convex [(v) green]—concave [(c) blue].
Luttrell and Kenakin, 2011). Potentially one of the most effi-
cient ways of generating this high-density drug response data is
the use of transcriptomics (Ruf et al., 2003; Gesty-Palmer et al.,
2013). It is now known that many “small molecule” drugs, for
G protein-coupled receptors or other targets, can indeed exert
strong transcriptomic and genomic responses (Golan et al., 2009;
Chadwick et al., 2011) that were previously considered to be
solely regulated by growth factor receptor systems. We have pre-
viously shown that the small molecule tricyclic AMI is able
to exert beneficial therapeutic actions in aged mice that pos-
sess a pathophysiological signature of Alzheimer’s disease (Oddo
et al., 2003; Chadwick et al., 2011). The actions of AMI seemed
to be strongly associated with the activation of neurotrophin-
like signaling pathways. Neurotrophins are large endogenous
growth factors that, via activation of their cognate receptors
(of the receptor tyrosine kinase family), entrain strongly neu-
roprotective signaling pathways (e.g., v-akt murine thymoma
viral oncogene homolog 1 (AKT-1) phosphorylation) as well as
regulating signaling pathways (e.g., extracellular signal-regulated
kinase 1/2 (ERK1/2) phosphorylation) and the expression of
markers (post-synaptic density protein 95 (PSD95)) linked with
neuronal development. The three primary neurotrophin ligands
are NGF, BDNF, and neurotrophin-3 (NT3). Respectively these
ligands activate their cognate neurotrophic tyrosine kinase recep-
tors (NTRK), i.e., NTRK1, NTRK2 and NTRK3. The majority
of research into these neurotrophin systems has focused on the
therapeutic benefits of NGF and BDNF signaling. In Alzheimer’s
disease animals we previously found that the beneficial actions
of AMI appeared to stem from its ability to mimic the actions
of BDNF, rather than that of NGF. This finding was unexpected
as AMI is considered a “small” drug molecule (0.277 kDa) while
BDNF is approximately 13 kDa in mass, therefore despite their
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completely different physico-chemical properties they seemed to
share strong functional analogy in the central nervous system
of aged and diseased mice. We therefore chose to investigate,
at the transcriptomic response level, whether Plurigon would
be able to assist in the characterization of structures indica-
tive of specific forms of pharmacological activity, such as neu-
roprotective and neurodevelopmental mechanisms. Stimulation
of human clonal neuronal cells, SH-SY5Y, with AMI, BDNF
or NGF followed by RNA extraction (8 h later) and microar-
ray analysis revealed significant transcriptomic activity of all
three ligands (AMI-Table S12, BDNF-Table S13, NGF-Table S14)
compared to vehicle-treated cells. When we compared these
three transcriptomic effects we again found that indeed the
genomic response patterns to AMI and BDNF were more sim-
ilar to each other than AMI to NGF or even BDNF to NGF
(Figure 6A). Mirroring this transcriptomic similarity between
AMI and BDNF we also found that at the cellular signaling
level the response patterns for ERK1/2 (Figure 6B) and AKT-1
phosphorylation (Figure 6C) (kinases linked to neurodevelop-
mental and neuroprotective activities, respectively) to AMI and
BDNF were similar in magnitude and temporal nature to each
other and differential to the signaling patterns of NGF in these
cells. Connected to these findings we were also able to demon-
strate that only cellular treatment (20min) with AMI and BDNF
resulted in the increase in phosphotyrosine content of immuno-
precipitated NTRK2 (cognate receptor for BDNF) (Figure 6D).
In contrast, NGF cellular stimulation (20min) resulted in the
increase of phosphotyrosine content of the NTRK1 receptor
(Figure 6D). These data therefore demonstrate that despite con-
siderable physico-chemical differences AMI is able to mimicmany
of the functional effects of BDNF. We then assessed whether
this distinction could be translated into distinct Plurigon struc-
tures. Using transcripts commonly activated between AMI, BDNF
and NGF at the 8 h time point (Table S15-AMI, Table S16-
BDNF, Table S17-NGF) we found after creating the plurigons for
these three ligands that strong visual distinctions were appar-
ent (Figures 7A,B, S9, S10). In each of these example plurigons
the structural idiosyncrasies demonstrated a strong similarity
between the AMI and BDNF structures, both of which were
distinguishable from the NGF structures. With respect to the
potential molecular mechanism of BDNFmimicry and the thera-
peutic effects observed in Alzheimer’s disease animals (Chadwick
et al., 2011) we found that chronic cellular treatment (24 h) with
AMI resulted in a disruption of the cellular disposition (mea-
sured using subcellular biochemical separation) of components
(anterior pharynx defective 1 homolog A (APH1A) and nicastrin
(NCSTN)) of the amyloid precursor protein (APP) processing
complex, γ-secretase (Figure S11A). Aberrant processing of APP
is a hallmark of the Alzheimer’s disease pathological process.
In addition to changes in cellular distribution of components
of the γ-secretase complex we found alterations in NTRK2 and
the multifunctional adapter protein β-arrestin 2 (ARRB2). We
FIGURE 6 | Amitriptyline demonstrated functional signaling similarities
with brain-derived neurotrophic factor in human neuronal cells. (A)
Venn diagram analysis of the gene transcripts significantly altered in their
expression (compared to vehicle-treated control) in human SH-SY5Y cells
8 h after stimulation with amitriptyline (AMI-black), brain-derived
neurotrophic factor (BDNF-red) and nerve growth factor (NGF-blue).
(B) Time course data for AMI (10nM)-, BDNF (10ng/mL)- or NGF
(10ng/mL)-mediated extracellular signal-regulated kinase 1/2 (ERK1/2)
phosphorylation which denotes kinase activation (measured with p-ERK1/2
phosphospecific antibody). Statistical significance (Student’s t-test)
(∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001) for AMI and BDNF compared to NGF
was measured at each time point from three independent experiments. (C)
Time course data for AMI-, BDNF- or NGF-mediated v-akt murine thymoma
viral oncogene homolog 1 (AKT1) phosphorylation which denotes kinase
activation (measured with p-AKT1 phosphospecific antibody). Statistical
significance (Student’s t-test) (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001) for AMI
and BDNF compared to NGF was measured at each time point from three
independent experiments. (D) Treatment of SH-SY5Y cells (20min) with
AMI (10nM) or BDNF (10ng/ml) results in the increase of phosphotyrosine
content [measured using anti-phosphotyrosine (p-Tyr) antibody—PY20] of
immunoprecipitated (IP) NTRK2, while only NTRK1 is significantly
phosphorylated by NGF.
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FIGURE 7 | Structural analogy between AMI and BDNF plurigons. (A)
Panels 1, 2, and 3 depict representative plurigons for AMI-, BDNF- and
NGF-stimulated transcriptomic datasets. Panels 4–6 depict the coordinate
locations for plurigons in panels 1–3. In each plurigon window (4–6) a
region of structural divergence between the plurigon structures in
highlighted in a yellow box. This region is expanded (panels 7–9) to
demonstrate the similarity in structural region between AMI and BDNF and
their diversity from NGF. (B) Distinct secondary example of structural
analogy between AMI and BDNF plurigons compared to NGF. The panel
enumeration pattern is identical to (A).
subsequently found that acute AMI treatment (20min) affected
the physical interaction between NTRK2 and APP, APH1A and
ARRB2 (Figure S11B), suggesting that changes in this multipro-
tein complex may be associated with the beneficial therapeutic
actions of AMI.
BDNF possesses pharmacological activities that are highly
sought after for novel pharmacotherapeutics for aging-related
neurodegenerative disorders such as Alzheimer’s disease
(Mattson et al., 2004; Nagahara and Tuszynski, 2011). However,
many therapeutic strategies are not evaluated in appropriate
pharmacogenomic settings, i.e., most neurotherapeutic activity
is assessed in non-diseased, young healthy tissues or cells. The
genomic and transcriptomic effects of aging and disease are
considerable and can exert potent effects on drug efficacy (Lesko
and Schmidt, 2012; Liou et al., 2012). We recently developed
an in vitro mechanism to artificially “age” neuronal cells lines
(Chadwick et al., 2010) as the extraction and analysis of cen-
tral nervous tissues from aged experimental animals is highly
problematical due to cellular stress and rapid degradation.
We therefore applied this minimal peroxide exposure (7 days,
10 nM hydrogen peroxide treatment) to SH-SY5Y cells and
repeated the AMI, BDNF and NGF transcriptomic stimulation
protocols (Table S18-AMI, Table S19-BDNF, Table S20-NGF).
Upon inspection of the transcriptomic responses in these “aged,”
peroxide treated cells we found that in the “aged” cells AMI
was able to activate a transcriptomic response more similar
(25% conserved) to that in non-peroxide-treated control cells
than either BDNF (13% conserved) or NGF (15% conserved)
(Figure 8A). Perhaps linked to this we found that AMI possessed
a superior ability, compared to BDNF or NGF (all 10min
stimulation), to activate neuroprotective (AKT1, Figure 8B)
and neurodevelopmental (ERK, Figure 8C) signaling functions.
In addition to these rapid signaling effects of AMI we found
that with longer-term exposure (48 h), AMI demonstrated
an enhanced ability, compared to BDNF or NGF, to increase
the expression of the neurosynaptic developmental markers
(indicative of neurotrophin-like activity), post-synaptic density
95 (PSD95) and synapsin I (SYN1) (Figures 8D,E, respectively).
To investigate whether this cellular context, and ligand-specific,
alteration of pharmacological activity could be associated with
plurigon structure we generated comparable plurigons from
transcripts commonly activated by AMI, BDNF and NGF in these
peroxide-treated “aged” cells (Table S21-AMI, Table S22-BDNF,
Table S23-NGF) (Figure 9A). In the “aged” neuronal cells the
AMI plurigon structures now demonstrated a more singular
structure compared to those for BDNF or NGF (Figures 9B–E:
COM coordinates, r, average radius, surface area). As we had
previously shown that the actions of AMI appear to mimic
the beneficial capacities of BDNF we applied bioinformatic
annotation to the AMI-controlled transcripts more similarly
regulated (ranked by expression score similarity) to BDNF as
opposed to NGF (Table S24). Using the NIH DAVID Analytical
Suite (http://david.abcc.ncifcrf.gov/) to generate KEGG (Kyoto
Encyclopedia of Genes and Genomes (http://www.genome.jp/
kegg/) pathway output from these AMI-regulated, BDNF-like,
transcripts, we found that the only signaling pathway signifi-
cantly populated (p < 0.05) by this gene list was the hsa047223:
Neurotrophin signaling pathway (http://www.genome.jp/)
(kegg-bin/show_pathway?hsa04722) (Table S25).
We assessed, at the protein level, these cell context-specific
actions of AMI, by validating several transcript protein products
of genes differentially regulated by all three ligands that showed a
preference for BDNF-like activity (Table S24). We found that 48 h
after exposure, AMI was able to cause highly selective and unique
alterations in the expression of MBOAT2 (membrane bound
O-acyltransferase domain containing 2: Figure 9F), NDUFB10
(NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10:
Figure 9G), NRAS (neuroblastoma RAS viral (v-ras) oncogene
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FIGURE 8 | Chronic low-dose peroxide treatment of human neuronal
cells differentially affects stimulatory ligand behavior. (A) Venn
analysis of significant gene transcriptome regulatory activity for AMI,
BDNF and NGF both in control SH-SY5Y neurons (treated with vehicle)
and SH-SY5Y neurons previously exposed to 10 nM hydrogen peroxide for
7 days (peroxide). The percentage of transcription conservation between
control and peroxide states is indicated for AMI, BDNF, and NGF. (B)
AMI (20min treatment) possesses a significantly better ability to activate
AKT1 and ERK1/2 (C) in peroxide pre-treated cells compared to BDNF
(red bars) or NGF (blue bars). AMI (48h treatment) also possessed a
significantly greater ability to elevate the expression of PSD95 (D) and
synapsin I (E) in peroxide pre-treated cells compared to BDNF or NGF.
Statistical significance was measured over three independent experiments
with a Student’s t-test (∗p < 0.05, ∗∗p < 0.01).
FIGURE 9 | Chronic peroxide treatment of human neuronal cells reveals
idiosyncratic AMI-derived plurigon structure and selective protein
expression regulation. (A) Plurigon structures for AMI (panel 1),
BDNF (panel 2) and NGF (panel 3)-mediated transcriptional activity in
peroxide-treated SH-SY5Y cells. Panels 4–6 indicate the identical coordinate
locations for the three plurigon structures in panels 1–3. The red COM vector
line for each of the plurigon structures is depicted in panels 7–9. The COM
vector line for the AMI plurigon is clearly distinct from the two more similar
BDNF and NGF COM vector lines. (B) COM coordinate analysis for AMI,
BDNF and NGF plurigon structures. AMI-derived plurigons demonstrate a
significantly different r calculation (C), average radius from core (D) and
surface area (E) compared to BDNF- and NGF-derived plurigon structures.
AMI treatment (48h) of peroxide-exposed SH-SY5Y cells engenders an
idiosyncratic, and statistically distinct, cellular expression pattern, compared
to BDNF and NGF, of MBOAT2 (F), NDUFB10 (G), NRAS (H), and TMED1 (I).
Experiments in panels (F–I) were performed in triplicate and statistical
significance was assessed using a Student’s t-test (∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001).
homolog: Figure 9H) and TMED1 (transmembrane emp24 pro-
tein transport domain containing 1: Figure 9I). Therefore, with
respect to the actions of AMI in the “aged” neuronal tissue,
we have seen that a strong alteration in its plurigon struc-
ture (Figure 9) is associated with selective signaling (Figure 8)
and protein expression changes (Figure 9) while still retain-
ing a strongly pro-neurotrophic signaling activity (Table S25).
Therefore, Plurigon, in association with classical protein biochem-
istry and informatic techniques is able to assist in the identifi-
cation of activity patterns of “small molecule” compounds that
possess a strong neuroprotective activity even in aged/damaged
neuronal tissue.
CONCLUSIONS
Given the increasing use of high-dimensionality data in many
disciplines, including specifically biomedical research, the devel-
opment of our application Plurigon serves as a mechanism to
assist human-aided feature extraction. Plurigonmay also be capa-
ble of bringing a larger audience to high-dimensionality data and
represents a mechanism to open doors for integrated solutions
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to biological and biomedical problems. Plurigon also serves as
a potential alternative to other standard forms of complex data
analysis such as PCA and also as a complementary system to
other excellent high-dimensionality suites such as Ggobi and
Ayasdi Iris. One specific feature of Plurigon that may assist in
comparative studies is its strong standardized structural plat-
form. This is in contrast to the more “freeform” nature of
visualizers such as Iris. A strong expected structural platform
may facilitate simpler comparisons between minimally-distinct
datasets, but in other circumstances it is also possible that a
more freeform topological data interpretation may be supe-
rior. The nature of the data corpus, the personal preferences
of the user and the required form of answers from the data
should all combine to influence the choice of application used.
Due to its ability to condense multivariate data into a visu-
ally interpretable form, Plurigon can lay the groundwork for
novel methods, experimental design, and new discoveries in a
variety of scientific fields ranging frommolecular biology to com-
putational linguistics, genomics to proteomics, bioinformatics
to pharmacology.
Here we have described the generation and implementation,
in three varied but synergistic biomedical work paradigms, i.e.,
hypothalamic age patterns, genotypic analysis of age-modifying
proteins such as GIT2 (Chadwick et al., 2012) and the pharma-
cogenomic investigation of small molecule neurotrophic ligands.
Our current appreciation of the full gamut of Plurigons’ utility
will no doubt be expanded once the application is transferred to
a diverse range of investigators in different disciplines. Therefore,
it is highly likely, and desirable, that further significant advance-
ments in analysis, classification and feature extraction will be
made in the future. The relative simplicity of the Plurigon concept
underlies the enormous potential for comparative data analysis.
For example we propose that outline-transition analysis, i.e., the
effect of feature “crypticism” (obscuration or revelation of outline
features based on differential visual aspects and scale: Figure 10)
in the plurigon may be an interesting avenue for further feature
extraction. Another example for potential future development
for Plurigon data outputs is the synergism of physical plurigon
structures with TUIs. Hence, in addition to the standard Plurigon
output file formats, the derived.vrml or.wrl files can be employed
for physical 3-dimensional rendering/printing of a plurigon of
choice (Figure 11). The generation of an actual physical output
of Plurigon, with 3-dimensional printing using a Z Corp ZPrinter
650 (http://www.sculpteo.com/en/) may allow future users to eas-
ily connect their high-dimensionality data to machine-learning
applications using TUIs (Ishii et al., 2012) that can extract more
physically-relevant object data outputs.
When data dimensionality reaches a certain threshold, it
becomes challenging even for advanced computers to process
such data. Aside from the sheer infeasibility of computa-
tion, problems of noise, sparseness and statistical insignificance
increase dramatically as the number of dimensions increases. To
this end, a common practice is to preprocess data with feature
extraction and dimensionality reduction techniques such as PCA,
Latent Semantic Analysis (LSA), or Semidefinite Embedding
(SDE). A collective group of different feature extraction meth-
ods can be effective for the classification of a broad spectrum of
entities (Orlov et al., 2008). Extraction is often performed after
various mathematical transforms have been applied to the orig-
inal data set to increase the number of total usable features. As
such, feature extraction from Plurigon may therefore potentially
be useful as additional input features for applied machine learn-
ing algorithms. One potential advantage that Plurigon possesses is
the ability for humans to easily participate in the genesis of diverse
FIGURE 10 | Future developments for Plurigon feature output and
analysis. Outline recognition of cryptic feature generation. As Plurigon
generates a reliable-oriented three-dimensional figure it is likely that surface
features may indeed have an impact upon the appreciable visual nature of
the plurigon through obscuring other data points. Such an effect therefore
generates an entirely new level of data that other applications may not due
to their free-form structure or lack of three-dimensional rendering. To
attempt to quantify this effect, and also create additional extractable data
features for detailed data classification, we propose the following
methodology. (A) A single exemplary plurigon is chosen and for a given set
of coordinates for the axes an outline of the edge of plurigon can be
generated, indicated by the presence of the blue line in panel (B). This
trace can then be extracted in (C). With the same exemplary plurigon as in
(A), slight rotation around the vertical y axis (D) helps generate a novel
plurigon outline (E—red line) that also can be extracted (F). Even with small
rotations (in axis required) the plurigon outline can clearly change
[G—superimposition of (C) and (F) traces], due to both loss of features
from the visual field or also via obscuration of newly-oriented features with
respect to the plane of the viewer. To extract quantifiable features from
such effects line-length scanning can be used from any direction required in
the extracted trace box. In this case scanning line-length is determined by
the termination of the scan line (black) at the blue (H) or red (I) plurigon
trace outline. Extraction and matching of these scan lines [J,K; compared
with minor vertical shift to improve comparison in (L)] can be used
to discriminate divergent features of the plurigon based on this
perspective-regulated analysis. The number of numerical features such as
this can be easily scaled up or down based on the plurigon rotation angles
and the orientation and density of the trace outline scan lines.
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FIGURE 11 | Tangible-user interface outputs for Plurigon. (A) Rendering
of an exemplary Plurigon structure from a.wrl format file. (B) Actual physical
3-dimensional print-out of a Plurigon for potential TUI (tangible user
interface) applications and topological analysis.
feature extraction processes from familiar and potentially tangi-
ble sources. With efficient data visualization, a coordination of
efforts can be made for the efficient extraction of features either
directly from the Plurigon structure, or from the original data
set itself.
One potential important venue of future research for val-
idating the use of “data texturizers” such as Plurigon, or the
excellent Ayasdi Iris (Lum et al., 2013), as tools for visualization
and classification is the field of drug screening and discovery. In
our current work we have attempted to demonstrate that transi-
tional changes in plurigon structures are tightly associated with
complex changes in gene expression patterns, cellular signaling
activity and protein-protein interaction. In addition to this we
found that pharmacogenomic alterations in ligand (AMI) activ-
ity were mirrored in the subtle changes in plurigon structure
(Figure 9) and that these changes were strongly associated with
the maintenance of desirable drug activity patterns (Table S25).
In addition to aiding pharmacological research by interpreting
functional signaling patterns, the implementation of Plurigon to
disease diagnoses and classification may be an important future
use. Many disease processes, e.g., hypertension, Alzheimer’s dis-
ease or diabetes (Maudsley et al., 2011a), are often considered in
a monolithic sense. While the eventual diagnosis, e.g., elevated
blood pressure, compromised memory function, or excess glu-
cose in the urine, may seem to unify patients presenting those
data, it has been steadily proven over recent decades, assisted
by assay multiplexing and high-content analytical tools, that
these disorders can be fractionated into multiple distinct sub-
types (Maudsley et al., 2011a; Israel et al., 2012; Kota et al.,
2012; Zeller et al., 2012). Therefore, rather than considering them
singular entities they are actually the output function of hyper-
complex molecular signatures. As the ability to gather genome-
or proteome-wide levels of patient data becomes a reality, our
need to analyze and classify disease sub-groups becomes ever
more important. The ability to separate these complex disease
phenotypes will significantly enhance our ability to differentially
and specifically diagnose and treat these various “sub-conditions”
more effectively compared to monolithic treatment strategies.
Plurigon therefore may be able to assist in generating a readily
comparable platform for patient data classification and disease
spectrum analysis.
With the increasing prevalence of the Semantic Web (http://
www.w3.org/standards/semanticweb/) and drug-target databases
such as PubChem, Linked Open Drug Data (LODD), and
Chem2Bio2RDF, data mining for novel drug discovery is par-
ticularly promising (Shadbolt et al., 2006; Chen et al., 2010;
Samwald et al., 2011; Wang et al., 2011). Using mass analyti-
cal techniques such as genomics and protein mass spectrometry,
the generation of high-dimensionality data is now routine in
biomedical science. Currently, a significant degree of informat-
ics development has taken place for the compilation of mul-
tivariate drug-target response data in high-throughput assays,
standardized binary representation of compounds (PubChem
fingerprints), and rudimentary feature extraction on com-
pounds (atom pair similarities) (Cao et al., 2008). Therefore,
at the present time, with the creation of high-dimensionality
data analyzers, such as Plurigon, Ggobi and Iris follow-
ing the widespread implementation of mass data collec-
tion pipelines (genome/proteome-wide), we may soon see the
generation of highly predictive and nuanced structure-activity-
relationships (SAR) specifically modeled against pathophysio-
logical scenarios. We have already pioneered this approach,
in a considerably low-scale manner, for the discovery and
whole-animal SAR analysis of palliative agents for Huntington’s
disease (Martin et al., 2012b). In this study we were able
to predict whole-animal therapeutic efficacy (using multiple
biomedical indices) from complementary pathophysiological-
pharmacogenomic-pattern investigation. In the future therefore,
small molecular nuances may be able to be linked to subtle
plurigon deformations induced by subtle “systems-level” tran-
scriptional or proteomic responses in the experimental animal or
even in clinical patients.
It is important to note that data texturizers such as Plurigon
should rationally be employed, in a user-defined manner, along-
side, and not instead of, conventional data analysis methods such
as PCA, LSA, and SDE. Some of these techniques though do
possess inherent deficiencies, such as PCA’s inability to handle
complex non-linearity, while in contrast many groups are begin-
ning to appreciate the tremendous categorizing power of the
human eye linked to our excellent shape-recognition capacities.
We have shown with our present data that there may indeed
be circumstances where novel applications such as Plurigon can
assist where the implementation of PCA is not ideal. However,
the specific use of one tool or application over another is entirely
dependent on a combination of user preference and suitability of
the datasets in use. With potential future user-created Plurigon
developments additional and novel extracted features may serve
as useful discriminatory identifiers in cases where traditional
features may not.
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Figure S1 | Website platform for Plurigon application home. The Plurigon
application is available in Windows-PC, Mac OSX and Linux formats.
Figure S2 | Flowchart diagram for the generation and operation of the
Plurigon application.
Figure S3 | Structural diversity between mean WT and mean HET plurigon
structures. Panels 1 and 2 depict mean WT and HET plurigons,
respectively. Panels 3 and 4 demonstrate the identical coordinate location
of the plurigons in panels 1 and 2. The yellow inset box highlights the
region of structural diversity between WT and HET. Panels 5 and 6 depict
expanded views of the highlighted box in panels 3 and 4. Yellow arrows
indicate the regions of structural diversity.
Figure S4 | Structural diversity between mean WT and mean HET plurigon
structures. Panels 1 and 2 depict mean WT and HET plurigons,
respectively. Panels 3 and 4 demonstrate the identical coordinate location
of the plurigons in panels 1 and 2. The yellow inset box highlights the
region of structural diversity between WT and HET. Panels 5 and 6 depict
expanded views of the highlighted box in panels 3 and 4. Yellow arrows
indicate the regions of structural diversity.
Figure S5 | Structural diversity between mean WT and mean HET plurigon
structures. Panels 1 and 2 depict mean WT and HET plurigons,
respectively. Panels 3 and 4 demonstrate the identical coordinate location
of the plurigons in panels 1 and 2. The yellow inset box highlights the
region of structural diversity between WT and HET. Panels 5 and 6 depict
expanded views of the highlighted box in panels 3 and 4. Yellow arrows
indicate the regions of structural diversity.
Figure S6 | Structural diversity between mean WT and mean HET plurigon
structures. Panels 1 and 2 depict mean WT and HET plurigons,
respectively. Panels 3 and 4 demonstrate the identical coordinate location
of the plurigons in panels 1 and 2. The yellow inset box highlights the
region of structural diversity between WT and HET. Panels 5 and 6 depict
expanded views of the highlighted box in panels 3 and 4. Yellow arrows
indicate the regions of structural diversity.
Figure S7 | Structural diversity between mean WT and mean HET plurigon
structures. Panels 1 and 2 depict mean WT and HET plurigons,
respectively. Panels 3 and 4 demonstrate the identical coordinate location
of the plurigons in panels 1 and 2. The yellow inset box highlights the
region of structural diversity between WT and HET. Panels 5 and 6 depict
expanded views of the highlighted box in panels 3 and 4. Yellow arrows
indicate the regions of structural diversity.
Figure S8 | PCA-mediated alignment of WT and HET murine multi-tissue
transcriptomic data. The three-dimensional PCA plot depicts the data
points provided in Table S10. Red plus signs indicate WT data and the
blue crosses indicate HET data.
Figure S9 | Structural diversity between AMI, BDNF and NGF plurigon
structures. Panels 1, 2 and 3 depict AMI-, BDNF- and NGF-derived
plurigons, respectively. Panels 4, 5 and 6 demonstrate the identical
coordinate location of the plurigons in panels 1–3. The yellow inset box
highlights the region of structural diversity between the three plurigons.
Panels 7–9 depict expanded views of the highlighted box containing the
feature demonstrating similarity between AMI and BDNF compared to
NGF in panels 4–6.
Figure S10 | Structural diversity between AMI, BDNF and NGF plurigon
structures. Panels 1, 2 and 3 depict AMI-, BDNF- and NGF-derived
plurigons, respectively. Panels 4, 5 and 6 demonstrate the identical
coordinate location of the plurigons in panels 1–3. The yellow inset box
highlights the region of structural diversity between the three plurigons.
Panels 7–9 depict expanded views of the highlighted box containing the
feature demonstrating similarity between AMI and BDNF compared to
NGF in panels 4–6.
Figure S11 | AMI-mediated subcellular expression and protein-protein
interaction changes in human neuronal cells. (A) Subcellular
fractionation (fraction lanes 1–9: Golgi region = VAMP4-enriched lanes
4–8; endoplasmic reticulum region = calreticulin-enriched lanes 1–5) of
human SH-SY5Y cells treated with AMI for 48 h reveals alterations in
expression patterns of the amyloid precursor protein (APP) processing
factors nicastrin (NCSTN) and anterior pharynx defective 1 homolog A
(APH1A), the NTRK2 receptor and the multifunctional adaptor protein
β-arrestin 2 (ARRB2). (B) AMI treatment (10 nM) of SH-SY5Y cells
results in the altered co-immunoprecipitation of APP (reduced), APH1A
(increased) and ARRB2 (increased) with the NTRK2 receptor
(representative western blots and associated histograms below).
Experiments in panel (B) were performed in triplicate and statistical
significance was assessed using a Student’s t -test (∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001).
Table S1 | Primary antibody sources and employed dilution factors for
selective western blotting.
Table S2 | Conserved hypothalamic transcriptomic expression data from 6
month old female mice. The transcriptomic data from separate (F6-1, F6-2,
F6-3) 6 month old mice was compared to 3 month old gender-matched
control hypothalamic expression values.
Table S3 | Conserved hypothalamic transcriptomic expression data from
12 month old female mice. The transcriptomic data from separate (F12-1,
F12-2, F12-3) 12 month old mice was compared to 3 month old
gender-matched control hypothalamic expression values.
Table S4 | Conserved hypothalamic transcriptomic expression data from
18 month old female mice. The transcriptomic data from separate (F18-1,
F18-2, F18-3) 18 month old mice was compared to 3 month old
gender-matched control hypothalamic expression values.
Table S5 | Conserved hypothalamic transcriptomic expression data from 6
month old male mice. The transcriptomic data from separate (M6-1, M6-2,
M6-3) 6 month old mice was compared to 3 month old gender-matched
control hypothalamic expression values.
Table S6 | Conserved hypothalamic transcriptomic expression data from
12 month old male mice. The transcriptomic data from separate (M12-1,
M12-2, M12-3) 12 month old mice was compared to 3 month old
gender-matched control hypothalamic expression values.
Table S7 | Conserved hypothalamic transcriptomic expression data from
18 month old male mice. The transcriptomic data from separate (M18-1,
M18-2, M18-3) 18 month old mice was compared to 3 month old
gender-matched control hypothalamic expression values.
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Table S8 | Wildtype (WT) murine transcriptomic data from multiple
isolated tissues. Datasets are arranged alphanumerically with the
following nomenclature: WT1 to WT16.
Table S9 | GIT2 heterozygous (HET) murine transcriptomic data from
multiple isolated tissues. Datasets are arranged alphanumerically with the
following nomenclature: HET1 to HET19.
Table S10 | Standard PCA analysis of WT and HET genotypic datasets.
PCA was applied to reduce data dimensionality to three primary
dimensions, D1, D2 and D3. Using these three dimensions the two
genotype groups appeared non-separable.
Table S11 | Plurigon structural concavity/convexity analysis. The structural
nature of three coincident facets of each dataset plurigon are color coded
(red, green or blue) and their physical nature (convex (VEX) or concave
(CAVE)) is denoted.
Table S12 | Human neuronal cell (SH-SY5Y) transcriptomic effects induced
by amitriptyline exposure. For each amitriptyline (AMI) regulated transcript
the official Gene Symbol, z-ratio and transcript description are indicated.
Table S13 | Human neuronal cell (SH-SY5Y) transcriptomic effects induced
by brain-derived neurotrophic factor exposure. For each brain-derived
neurotrophic factor (BDNF) regulated transcript the official Gene Symbol,
z-ratio and transcript description are indicated.
Table S14 | Human neuronal cell (SH-SY5Y) transcriptomic effects induced
by nerve growth factor exposure. For each nerve growth factor (NGF)
regulated transcript the official Gene Symbol, z-ratio and transcript
description are indicated.
Table S15 | Conserved neuronal transcriptomic expression data from
amitriptyline-treated clonal human cells. Transcriptomic gene regulation
was measured from amitriptyline (AMI)-treated SH-SY5Y neuronal cell
batches (AMI-1, AMI-2, AMI-3). The transcriptomic data from the three
separate experiments was compared to gene expression levels in vehicle
(phosphate-buffered saline)-treated control SH-SY5Y cells.
Table S16 | Conserved neuronal transcriptomic expression data from
brain-derived neurotrophic factor-treated clonal human cells.
Transcriptomic gene regulation was measured from brain-derived
neurotrophic factor (BDNF)-treated SH-SY5Y neuronal cell batches
(BDNF-1, BDNF-2, BDNF-3). The transcriptomic data from the three
separate experiments was compared to gene expression levels in vehicle
(phosphate-buffered saline)-treated control SH-SY5Y cells.
Table S17 | Conserved neuronal transcriptomic expression data from nerve
growth factor-treated clonal human cells. Transcriptomic gene regulation
was measured from nerve growth factor (NGF)-treated SH-SY5Y neuronal
cell batches (NGF-1, NGF-2, NGF-3). The transcriptomic data from the
three separate experiments was compared to gene expression levels in
vehicle (phosphate-buffered saline)-treated control SH-SY5Y cells.
Table S18 | Transcriptomic effects of amitriptyline in human neuronal cells
(SH-SY5Y) cells pre-treated with chronic minimal levels of hydrogen
peroxide. For each amitriptyline (AMI) regulated transcript in the
peroxide-treated SH-SY5Y cells the official Gene Symbol, z-ratio and
transcript description are indicated.
Table S19 | Transcriptomic effects of brain-derived neurotrophic factor in
human neuronal cells (SH-SY5Y) cells pre-treated with chronic minimal
levels of hydrogen peroxide. For each brain-derived neurotrophic factor
(BDNF) regulated transcript in the peroxide-treated SH-SY5Y cells the
official Gene Symbol, z-ratio and transcript description are indicated.
Table S20 | Transcriptomic effects of nerve growth factor in human
neuronal cells (SH-SY5Y) cells pre-treated with chronic minimal levels of
hydrogen peroxide. For each nerve growth factor (NGF) regulated
transcript in the peroxide-treated SH-SY5Y cells the official Gene Symbol,
z-ratio and transcript description are indicated.
Table S21 | Conserved neuronal transcriptomic expression data from
pre-peroxidated amitriptyline-treated clonal human cells. Transcriptomic
gene regulation was measured from amitriptyline (AMI)-treated SH-SY5Y
neuronal cell batches (AMI-1, AMI-2, AMI-3) that were pre-conditioned to
mimic oxidative neurodegeneration with a continuous 7 day treatment
with 10nM hydrogen peroxide. The transcriptomic data from the three
separate experiments was compared to gene expression levels in vehicle
(phosphate-buffered saline)-treated control SH-SY5Y cells that were also
treated with 10 nM hydrogen peroxide as well.
Table S22 | Conserved neuronal transcriptomic expression data from
pre-peroxidated brain-derived neurotrophic factor-treated clonal human
cells. Transcriptomic gene regulation was measured from brain-derived
neurotrophic factor (BDNF)-treated SH-SY5Y neuronal cell batches
(BDNF-1, BDNF-2, BDNF-3) that were pre-conditioned to mimic oxidative
neurodegeneration with a continuous 7 day treatment with 10nM
hydrogen peroxide. The transcriptomic data from the three separate
experiments was compared to gene expression levels in vehicle
(phosphate-buffered saline)-treated control SH-SY5Y cells that were also
treated with 10 nM hydrogen peroxide as well.
Table S23 | Conserved neuronal transcriptomic expression data from
pre-peroxidated nerve growth factor-treated clonal human cells.
Transcriptomic gene regulation was measured from nerve growth factor
(NGF)-treated SH-SY5Y neuronal cell batches (NGF-1, NGF-2, NGF-3) that
were pre-conditioned to mimic oxidative neurodegeneration with a
continuous 7 day treatment with 10 nM hydrogen peroxide. The
transcriptomic data from the three separate experiments was compared
to gene expression levels in vehicle (phosphate-buffered saline)-treated
control SH-SY5Y cells that were also treated with 10 nM hydrogen
peroxide as well.
Table S24 | Similarity score calculations for BDNF-like AMI-regulated
transcripts. A relative similarity score for AMI-regulated transcripts that
possessed a regulatory mode more akin to BDNF than compared to NGF
was calculated as the follows. The modulus of the ((AMI score-NGF
score)/(AMI score-BDNF score)) was obtained and transcripts possessing
a modulus of over 1 were considered to be more AMI-BDNF correlated
than AMI-NGF correlated.
Table S25 | KEGG pathway analysis for AMI-regulated, BDNF-like,
transcripts in peroxide-treated human neuronal cells. Using the
NIH-DAVID Bioinformatic Suite (http://david.abcc.ncifcrf.gov/) we
annotated the AMI-regulated, BDNF-like, transcripts stimulated by AMI
treatment of artificially “aged” neuronal tissue. For each human signaling
pathway the probability of geneset enrichment (P-Value), the enrichment
relative to a scaled input from the human genome (Fold Enrichment) and
the specific genes in the input list that populate (n ≥ 2) the assessed
pathways. The only significantly populated signaling pathway was the
hsa047223: neurotrophin signaling pathway.
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